These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29326922)

  • 21. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014.
    Patel RC; Vellozzi C; Smith BD
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):12-9. PubMed ID: 27168656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015.
    van Santen DK; van der Helm JJ; Lindenburg K; Schim van der Loeff M; Prins M
    Int J Drug Policy; 2017 Sep; 47():95-101. PubMed ID: 28606392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV point-of-care screening programme and treatment options for people who use drugs in a metropolitan area of Southern Italy.
    Persico M; Masarone M; Aglitti A; Armenante C; Giordano A; Guardiola A; Raimondi G; Contaldi C; Nigro C; Marena G; De Luna A
    Liver Int; 2019 Oct; 39(10):1845-1851. PubMed ID: 31169953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Training Providers of People Who Use Drugs to Offer Hepatitis C Treatment: A Washington State Initiative.
    James JR; Tsui JI
    Subst Abus; 2023; 44(1):86-90. PubMed ID: 37226904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic.
    Norton BL; Fleming J; Bachhuber MA; Steinman M; DeLuca J; Cunningham CO; Johnson N; Laraque F; Litwin AH
    Int J Drug Policy; 2017 Sep; 47():196-201. PubMed ID: 28811158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care.
    Lazarus JV; Herranz A; Picchio CA; Villota-Rivas M; Rodríguez A; Alonso JM; Moratinos A; Perrotta A; Tegeo E; Bibiloni F; Buti M; Vilella À
    BMJ Open; 2021 Oct; 11(10):e053394. PubMed ID: 34675021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
    Blackburn NA; Patel RC; Zibbell JE
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Mobile Health Intervention to Improve Hepatitis C Outcomes Among People With Opioid Use Disorder: Protocol for a Randomized Controlled Trial.
    Hochstatter KR; Gustafson DH; Landucci G; Pe-Romashko K; Maus A; Shah DV; Taylor QA; Gill EK; Miller R; Krechel S; Westergaard RP
    JMIR Res Protoc; 2019 Aug; 8(8):e12620. PubMed ID: 31373273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care.
    Socías ME; Shannon K; Montaner JS; Guillemi S; Dobrer S; Nguyen P; Goldenberg S; Deering K
    Can J Gastroenterol Hepatol; 2015; 29(8):411-6. PubMed ID: 26492129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status.
    van Santen DK; van der Helm JJ; Grady BP; de Vos AS; Kretzschmar ME; Stolte IG; Prins M
    AIDS; 2014 Nov; 28(17):2589-99. PubMed ID: 25211439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study.
    Ryan P; Valencia J; Cuevas G; Troya J; Ramon C; Rodríguez A; Torres-Macho J; Muñoz-Gómez MJ; Canorea I; Vázquez-Morón S; Resino S
    Int J Drug Policy; 2021 Jun; 92():103134. PubMed ID: 33517130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis C virus infection among key populations in China: A systematic review.
    Liu CR; Li X; Chan PL; Zhuang H; Jia JD; Wang X; Lo YR; Walsh N
    Int J Infect Dis; 2019 Mar; 80():16-27. PubMed ID: 30529371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
    Brown JL; Gause NK; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engagement in the Hepatitis C care continuum among people who use drugs.
    Tofighi B; Lee JD; Sindhu SS; Chemi C; Leonard NR
    J Subst Use; 2020; 25(4):343-349. PubMed ID: 33041652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
    Valencia La Rosa J; Ryan P; Alvaro-Meca A; Troya J; Cuevas G; Gutiérrez J; Moreno S
    PLoS One; 2018; 13(10):e0204795. PubMed ID: 30281616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.
    Rostam-Abadi Y; Rafiemanesh H; Gholami J; Shadloo B; Amin-Esmaeili M; Rahimi-Movaghar A
    Harm Reduct J; 2020 Oct; 17(1):81. PubMed ID: 33087141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.